Clinical considerations of lipid target and goal in dyslipidemia control

Código QR

Clinical considerations of lipid target and goal in dyslipidemia control

Guardado en:

Detalles Bibliográficos
Autores principales:	Na-Qiong Wu, Jian-Jun Li
Formato:	article
Lenguaje:	EN
Publicado:	KeAi Communications Co., Ltd. 2016
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/02fa1ca9ad874cf6843bde9bc9135bc5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia
por: Hirotaka Fukami, et al.
Publicado: (2021)

Clinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemia
por: Frustaci AM, et al.
Publicado: (2015)

Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy
por: Wang L, et al.
Publicado: (2012)

Allium sativum, Hylocereus polyrhizus and its Combination Effectiveness on Lipid Profiles and Number of Foam Cells in Rats with Dyslipidemia
por: Wipi Sari Aisah, et al.
Publicado: (2019)

New guidelines and evidence for prevention and treatment of dyslipidemia and atherosclerotic cardiovascular disease in China
por: Da-Yi Hu
Publicado: (2017)

Progress of research on dyslipidemia accompanied by nephrotic syndrome
por: Min Tao, et al.
Publicado: (2020)

New insights into the pathological development of dyslipidemia in patients with hypothyroidism
por: Xin Su, et al.
Publicado: (2021)

Sulfatide-containing lipid perfluorooctylbromide nanoparticles as paclitaxel vehicles targeting breast carcinoma
por: Li X, et al.
Publicado: (2014)

FREQUENCY AND PATTERN OF DYSLIPIDEMIA IN CHILDREN WITH END STAGE RENAL DISEASE
por: Adeela Chaudhry, et al.
Publicado: (2019)

Verrucous plane xanthomas secondary to lipoprotein X dyslipidemia in the context of cholestatic fulminant hepatitis: A case report
por: Julie Dang, et al.
Publicado: (2021)

Docetaxel-loaded solid lipid nanoparticles as a basis for a targeted and dose-sparing personalized breast cancer treatment strategy
por: Danilova NV, et al.
Publicado: (2015)

Folate-modified lipid–polymer hybrid nanoparticles for targeted paclitaxel delivery
por: Zhang L, et al.
Publicado: (2015)

Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules
por: Clavreul A, et al.
Publicado: (2015)

Features of dyslipidemia in people with different body mass
por: K.V. Misyura
Publicado: (2017)

Impact of subintimal plaque modification (SPM) technique on failed intervention of coronary artery chronic total occlusion
por: Na-Qiong Wu, et al.
Publicado: (2021)

GLYCATED HEMOGLOBIN AS A BIOMARKER TO PREDICT DYSLIPIDEMIA IN TYPE 2 DIABETES MELLITUS
por: Abdul Moueed Tariq, et al.
Publicado: (2020)

Preparation and characterization of vinculin-targeted polymer&ndash;lipid nanoparticle as intracellular delivery vehicle
por: Wang J, et al.
Publicado: (2012)

Design, characterization, and clinical evaluation of argan oil nanostructured lipid carriers to improve skin hydration
por: Tichota DM, et al.
Publicado: (2014)

Microenvironmental considerations in the application of human mesenchymal stem cells in regenerative therapies
por: Steven J Greco, et al.
Publicado: (2008)

Relationship between Dietary Habits and Control of Lipid Profiles in Patients with Dyslipidemia Using Pravastatin
por: Seo Young Kang, et al.
Publicado: (2021)

Development and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivo
por: Feng L, et al.
Publicado: (2011)

In vivo biodistribution, anti-inflammatory, and hepatoprotective effects of liver targeting dexamethasone acetate loaded nanostructured lipid carrier system
por: Min-ting Wang, et al.
Publicado: (2010)

Clinical utility of targeted treatments in the management of epithelial ovarian cancer
por: Twu C, et al.
Publicado: (2012)

Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect
por: Rahman HS, et al.
Publicado: (2013)

A Cleverly Designed Novel Lipid Nanosystem: Targeted Retention, Controlled Visual Drug Release, and Cascade Amplification Therapy for Mammary Carcinoma in vitro
por: Zhao XZ, et al.
Publicado: (2020)

Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection
por: Wang W, et al.
Publicado: (2012)

Mixing lipids to manipulate the ionization status of lipid nanoparticles for specific tissue targeting
por: Shobaki N, et al.
Publicado: (2018)

A critical evaluation of the role of subcutaneous abatacept in the treatment of rheumatoid arthritis: patient considerations
por: Wells AF, et al.
Publicado: (2014)

Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]
por: Tahir N, et al.
Publicado: (2020)

Nanostructured lipid carrier-loaded hyaluronic acid microneedles for controlled dermal delivery of a lipophilic molecule
por: Lee SG, et al.
Publicado: (2013)

A Cleverly Designed Novel Lipid Nanosystem: Targeted Retention, Controlled Visual Drug Release, and Cascade Amplification Therapy for Mammary Carcinoma in vitro [Corrigendum]
por: Zhao XZ, et al.
Publicado: (2020)

TREM-1 links dyslipidemia to inflammation and lipid deposition in atherosclerosis
por: Daniel Zysset, et al.
Publicado: (2016)

Highly deformable and highly fluid vesicles as potential drug delivery systems: theoretical and practical considerations
por: Romero EL, et al.
Publicado: (2013)

Development of Taiwan’s strategies for regulating nanotechnology-based pharmaceuticals harmonized with international considerations
por: Guo JW, et al.
Publicado: (2014)

Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA
por: Shao Z, et al.
Publicado: (2015)

Influence of cationic lipid concentration on properties of lipid–polymer hybrid nanospheres for gene delivery
por: Bose RJC, et al.
Publicado: (2015)

MRI-guided targeting delivery of doxorubicin with reduction-responsive lipid-polymer hybrid nanoparticles
por: Wu B, et al.
Publicado: (2017)

Preoperative serum lipid profile and outcome in nonmetastatic colorectal cancer
por: Ting-Ting Hong, et al.
Publicado: (2016)

Novel therapeutic targets and agents for pediatric dyslipidemia
por: Bhuvana Sunil, et al.
Publicado: (2021)

THE ASSOCIATION OF PERIODONTAL DISEASES WITH TYPE 2 DIABETES MELLITUS AND DIABETES LINKED DYSLIPIDEMIA IN PAKISTANI POPULATION
por: Zara Khalid Khan, et al.
Publicado: (2021)